EGFR and metastatic colorectal cancer: Oxaliplatin and irinotecan, when combined with fluorouracil, are used as doublet regimens in the first-line treatment of metastatic colorectal cancer, often in combination with anti-EGFR (epidermal growth factor receptor) or anti-VEGF agents.